The risk of cancer in kidney transplant recipients may be reduced in those maintained on everolimus and reduced cyclosporine
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference23 articles.
1. Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies?;Meier-Kriesche;Am J Transplant,2004
2. Trends in kidney transplantation in Australia and New Zealand, 1993-2004;Chang;Transplantation,2007
3. Risk of metabolic complications in kidney transplantation after conversion to mTOR inhibitor: a systematic review and meta-analysis;Murakami;Am J Transplant,2014
4. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review;Gutierrez-Dalmau;Drugs,2007
5. The natural history of chronic allograft nephropathy;Nankivell;N Engl J Med,2003
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cardiovascular Outcomes in De Novo Kidney Transplant Recipients Receiving Everolimus and Reduced Calcineurin Inhibitor or Standard Triple Therapy: 24-month Post Hoc Analysis From TRANSFORM Study;Transplantation;2023-06-20
2. Immune Checkpoint Inhibitors in Solid Organ Transplant Recipients With Advanced Skin Cancers—Emerging Strategies for Clinical Management;Transplantation;2023-06-20
3. A systematic review and meta-analysis comparing everolimus and calcineurin inhibitors (CNIs) to mycophenolate and CNIs in kidney transplant patients;Korean Journal of Transplantation;2023-03-31
4. Scope and Consistency of Cancer Outcomes Reported in Randomized Trials in Kidney Transplant Recipients;Kidney International Reports;2023-02
5. Interventions After First Post-Transplant Cutaneous Squamous Cell Carcinoma: A Proposed Decision Framework;Transplant International;2022-11-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3